Zobrazeno 1 - 10
of 35
pro vyhledávání: '"KUMAR, SAHEL"'
Autor:
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, Saurabh Sharma, Jasmin Monpara, Anisha A. D'Souza, Deepakkumar Mishra, Kamatham Pushpa Tryphena, Satoru Kawakita, Shahid Khan, Mohd Azhar, Dharmendra Kumar Khatri, Ketan Patel, Raghu Raj Singh Thakur
Publikováno v:
Advanced Science, Vol 10, Iss 25, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/8f703b7274924d53b4f38a7d01b4fd1d
Autor:
Aayushi Lohia, Deepak Kumar Sahel, Mohd Salman, Vivek Singh, Indumathi Mariappan, Anupama Mittal, Deepak Chitkara
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 17, Iss 2, Pp 153-176 (2022)
CRISPR/Cas, an adaptive immune system in bacteria, has been adopted as an efficient and precise tool for site-specific gene editing with potential therapeutic opportunities. It has been explored for a variety of applications, including gene modulatio
Externí odkaz:
https://doaj.org/article/3ab14c82266e4a39ac11ddc10cdd9c17
Publikováno v:
In Neuroscience Letters 25 September 2019 710
Autor:
Reena, Jatyan, Prabhjeet, Singh, Deepak Kumar, Sahel, Y G, Karthik, Anupama, Mittal, Deepak, Chitkara
Publikováno v:
Journal of Controlled Release. 350:494-513
Temozolomide (TMZ), an imidazotetrazine, is a second-generation DNA alkylating agent used as a first-line treatment of glioblastoma multiforme (GBM). It was approved by FDA in 2005 and declared a blockbuster drug in 2008. Although TMZ has shown 100%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b704996d4474f9b8e341ca3c4885556
https://doi.org/10.1016/j.jconrel.2022.08.024
https://doi.org/10.1016/j.jconrel.2022.08.024
Autor:
Deepak Kumar Sahel, Sangam Giri Goswami, Reena Jatyan, Anupma Kumari, Anupama Mittal, Sivaprakash Ramalingam, Deepak Chitkara
Publikováno v:
Macromolecular Rapid Communications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bbfe84859a83398b3080499574a2e7d
https://doi.org/10.1002/marc.202300101
https://doi.org/10.1002/marc.202300101
Autor:
Deepak Kumar Sahel, Mohd Salman, Mohd Azhar, Sangam Giri Goswami, Vivek Singh, Manu Dalela, Sujata Mohanty, Anupama Mittal, Sivaprakash Ramalingam, Deepak Chitkara
Publikováno v:
Journal of Materials Chemistry B. 10:7634-7649
sgRNA/Cas9 ribonucleoproteins (RNPs) provide a site-specific robust gene-editing approach avoiding the mutagenesis and unwanted off-target effects. However, the high molecular weight (∼165 kDa), hydrophilicity and net supranegative charge (∼-20 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3cc1056c56e0bbb2c14e482f905d6e
https://doi.org/10.1039/d2tb00645f
https://doi.org/10.1039/d2tb00645f
Autor:
Abhay Tharmatt, Deepak Kumar Sahel, Kaisar Raza, Murali Monohar Pandey, Anupama Mittal, Deepak Chitkara
Publikováno v:
Journal of Drug Delivery Science and Technology. 83:104365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7a0336ec6b6533015da098abd3af5ca
https://doi.org/10.1016/j.jddst.2023.104365
https://doi.org/10.1016/j.jddst.2023.104365
Autor:
Tushar Date, Kaushik Kuche, Dasharath Chaudhari, Rohan Ghadi, Deepak Kumar Sahel, Deepak Chitkara, Sanyog Jain
Publikováno v:
ACS biomaterials scienceengineering. 8(6)
Triple-negative breast cancer (TNBC) cells show improved sensitivity for cisplatin therapy due to their defective DNA damage repair system. However, the clinical utilization of cisplatin is limited by dose-dependent systemic toxicities and chemoresis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b0fa99ec6f3cfd4defac9f0a1f1e1c3
https://pubmed.ncbi.nlm.nih.gov/35522530
https://pubmed.ncbi.nlm.nih.gov/35522530
Publikováno v:
Journal of Drug Delivery Science and Technology. 76:103672
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a90cc0fa4e2ce1c96e4ba8a69a9d257d
https://doi.org/10.1016/j.jddst.2022.103672
https://doi.org/10.1016/j.jddst.2022.103672
Autor:
Aayushi Lohia, Deepak Kumar Sahel, Mohd Salman, Vivek Singh, Indumathi Mariappan, Anupama Mittal, Deepak Chitkara
Publikováno v:
Asian journal of pharmaceutical sciences. 17(2)
CRISPR/Cas, an adaptive immune system in bacteria, has been adopted as an efficient and precise tool for site-specific gene editing with potential therapeutic opportunities. It has been explored for a variety of applications, including gene modulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd30e13243c5209514a7134eca0773ef
https://pubmed.ncbi.nlm.nih.gov/36320315
https://pubmed.ncbi.nlm.nih.gov/36320315